Abstract
Background
One third of global antmicrobial resistance deaths are attributed to drug resistant tuberculosis. Lost to follow-up is one of the causes of the development of acquired drug resistant tuberculosis. There is a gap in nationally representative reliable information on lost to follow-up among patients with drug-resistant tuberculosis in Ethiopia.
Objective
To estimate the pooled prevalence and associated factors of lost to follow-up among patients with drug resistant tuberculosis in Ethiopia.
Methods
Observational studies searched from PubMed, HINARI and CINAHL were screened for eligibility. After assessing the quality of studies, data were extracted using a checklist. Heterogeneity was assessed using forest plot, Q and I2. The random effects meta-analysis model was employed to pull the prevalence of lost to follow-up. Sub-group analysis and meta regression were performed to identify the sources of heterogeneity. Publication bias was assessed using funnel plots with Egger’s and Begg’s tests. Sensitivity analysis was performed to assess the influence of individual studies on the overall estimate. The odds ratios were used to measure associations.
Results
The review was performed among 11 studies of which 9 were cohort studies. The sample sizes ranged from 90 to 612 and comprised a total of 3,510 participants. The pooled prevalence of lost to follow-up was 8.66% (95% CI, 5.01–13.14) with a high heterogeneity (I2 = 93.49%, p<0.001). Pulmonary multi-drug resistant tuberculosis patients were 50% less likely to loss from follow-up compared to extra pulmonary tuberculosis patients.
Conclusion
There was a high prevalence of lost to follow-up among multi-drug resistant tuberculosis patients in Ethiopia. Anatomical site of tuberculosis was a significant factor affecting lost to follow-up. Strengthening the health care system and patient education should be given a due emphasis.
Registration number
CRD42020153326; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=153326.
Publisher
Public Library of Science (PLoS)
Reference38 articles.
1. World Health Organization. Global Tuberculosis Report 2019. Geneva; 2019.
2. The Global fund. Drug-resistant Tuberculosis. 2019. http://www.theglobalfund.org.
3. Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia;G Diriba;Infect Dis Poverty,2019
4. Federal Ministry of Health of Ethiopia. Guideline for program and clinical management of drug resistant tuberculosis. 5th ed. Addis Ababa, Ethiopia: FMOH; 2009.
5. Federal Ministry of Health. National Programmatic management of Drug resistant TB in Ethiopia: Participant’s manual. Addis Ababa: FMOH; 2019. pp. 46–58.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献